文献速递产科母胎医学妇科

妊娠期附件病变的影像学诊断:系统综述

Diagnostic imaging of adnexal lesions in pregnancy: systematic review.
PubMed 文献 · Ultrasound Obstet Gynecol · 2026-08-10

该系统综述纳入16项研究、1674例患者和1660个附件病变,评估妊娠期附件病变的影像特征及风险模型性能。良性病变占93.1%,交界性肿瘤和恶性各约3.4%和3.5%。超声可可靠评估,IOTA模型特异性70.0-90.2%、阴性预测值90.0-98.3%,但蜕膜化子宫内膜异位囊肿易误判为恶性。

要点

  • 妊娠期附件病变绝大多数为良性,交界性和恶性各约3.5%。
  • 交界性肿瘤和恶性肿瘤的影像特征与非妊娠期相似。
  • IOTA模型阴性预测值高,但蜕膜化子宫内膜异位囊肿易误分类。

核心结论

  • 超声可可靠评估妊娠期附件病变,IOTA模型维持高阴性预测值以排除恶性。
  • 蜕膜化子宫内膜异位囊肿与交界性肿瘤形态重叠,需专家鉴别。

研究设计与样本

  • PROSPERO注册的系统综述,检索至2025年8月1日,遵循PRISMA指南。
  • 纳入16项研究,共1674例患者和1660个附件病变,多数为回顾性超声研究。

主要发现

  • 排除6项仅良性病变研究后,良性占93.1%(1284/1379),交界性肿瘤3.4%(47/1379),恶性3.5%(48/1379)。
  • 常见良性病变:单纯囊肿39.0%(393/1007)、成熟囊性畸胎瘤24.2%(244/1007)、子宫内膜异位囊肿14.9%(150/1007)。
  • 蜕膜化见于11.8-39.5%的子宫内膜异位囊肿;交界性肿瘤中位大小88.0 mm,蜕膜化子宫内膜异位囊肿48.1 mm。
  • 交界性肿瘤多房实性占30.0%,蜕膜化子宫内膜异位囊肿22.4%;多数蜕膜化子宫内膜异位囊肿(83.9%)有1-3个乳头状突起,多数交界性肿瘤(66.7%)超过3个。

关键数值与推荐

  • IOTA两步策略和ADNEX模型单独应用特异性70.0-90.2%,阴性预测值90.0-98.3%。

临床怎么用

  • 妊娠期附件病变首选超声评估,可参考IOTA术语描述特征。
  • 对实性成分的囊肿,需警惕蜕膜化子宫内膜异位囊肿与交界性肿瘤的形态重叠。

局限性

  • 研究间异质性大,未进行模型性能的荟萃分析。
  • 多数纳入研究为回顾性设计。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To describe the imaging features of adnexal lesions during pregnancy and assess the performance of current models for the risk assessment of such lesions. METHODS: This was a PROSPERO-registered systematic review including studies published from inception to 1 August 2025 and was performed as per Preferred Reporting Systems for Systematic Reviews and Meta-Analysis guidance using Covidence software. Studies were included if they utilized an objective or standardized assessment of imaging features (based on the International Ovarian Tumor Analysis (IOTA) terms and definitions, or predefined categorical variables), expert description or quantitative data (such as lesion measurements and number of papillary projections) to assess the risk of adnexal lesions during pregnancy. Standardized extraction of imaging features was performed and classification of outcomes was based on histology, resolution or expert impression. Diagnostic model performance was also extracted. Meta-analysis of model performance was not performed owing to study heterogeneity. RESULTS: Overall, 3349 studies were screened, of which 40 underwent full-text review and 16 were included in the systematic review, comprising 1674 patients and 1660 adnexal lesions. Most included studies were retrospective and ultrasound-based. Excluding six studies that exclusively reported benign lesions, 93.1% (1284/1379) of patients had benign lesions, 3.4% (47/1379) had borderline ovarian tumors (BOTs) and 3.5% (48/1379) had malignant lesions. Excluding studies reporting exclusively on endometrioma, the most common benign adnexal lesions were simple cysts (39.0% (393/1007)), mature cystic teratomas (24.2% (244/1007)) and endometriomas (14.9% (150/1007)). Malignant lesions were most often epithelial ovarian cancer or metastases. Both BOTs and malignant lesions retained imaging characteristics comparable with those observed in non-pregnant women. Decidualization was present in 11.8-39.5% of reported endometriomas. While decidualized endometriomas (DEs) and BOTs typically share characteristics, experts noted distinguishing morphological features and behaviors. BOTs were larger (median, 88.0 mm vs 48.1 mm), and although both were predominantly unilocular-solid lesions, BOTs were relatively more often multilocular-solid (30.0% vs 22.4%) compared with DEs. Both showed high vascularity, with most cases having a color score of 3. Most DEs (83.9%) had one to three papillary projections, whereas most BOTs (66.7%) had more than three papillary projections. Diagnostic models, such as the IOTA two-step strategy and the Assessment of Different NEoplasias in the adneXa model alone, showed high specificity (70.0-90.2%) and negative predictive value (90.0-98.3%), but performance was limited by misclassification of DEs as malignant. CONCLUSIONS: Ultrasound can reliably assess adnexal lesions in pregnancy. DEs and BOTs can appear similar owing to their morphological overlap. Both BOTs and malignant lesions in pregnancy show morphology comparable with that in non-pregnant women, and IOTA models maintain a high negative predictive value for excluding malignancy in such cases. Future research should refine diagnostic tools to improve the differentiation of benign from malignant cysts with solid components. © 2026 The Author(s). Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Cooper N, Kotecha N, Novak A, et al. Diagnostic imaging of adnexal lesions in pregnancy: systematic review. Ultrasound Obstet Gynecol. 2026. PMID: 42576475. doi:10.1002/uog.70296

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。